In this episode of Longevity by Design, our host, Dr. Gil Blander, sits down with Dylan Livingston, CEO at the Alliance for Longevity Initiatives, and Dr. Brenda Eap to explore how public policy shapes the future of aging research. Dylan and Brendan share how their team pushes for legislation that supports healthy lifespan extension, aiming to bring longevity science into the center of national health priorities.

Dylan and Brendan explain why policy advocacy is crucial for securing funding for research, reducing regulatory hurdles, and establishing a clear path for new therapies. They outline recent successes, including building bipartisan support in Congress and expanding access to experimental treatments in states such as Montana. Throughout their discussion, Dylan shows how effective communication,  using stories and simple analogies, helps move longevity from the lab to lawmakers’ agendas.

The episode closes with practical advice for listeners. Dylan highlights the power of community, clear communication, and grassroots action as tools that help turn advanced science into real-world health gains.

Episode highlights:

[00:00:00]: Introduction
[00:01:00]: Overview of Longevity Policy and Research Funding
[00:02:00]: Backgrounds and Personal Journeys into Longevity Advocacy
[00:05:00]: Inspiration and Founding of Longevity Policy Organization
[00:07:00]: Scientific Training and Motivation for Policy Work
[00:09:00]: Mission and Approach of Longevity Advocacy Organization
[00:10:00]: Policy Advocacy’s Role in Advancing Longevity Research
[00:12:00]: Gaps in Funding and the Importance of Government Engagement
[00:13:00]: Experiences with Policy Events and Realizations about Advocacy
[00:14:00]: Early Accomplishments and Congressional Engagement
[00:15:00]: Building Bipartisan Support and the Longevity Science Caucus
[00:16:00]: Legislative Engagement and Policy Paper Development
[00:17:00]: State-Level Policy Wins and Expansion of Right to Try Laws
[00:19:00]: Rationale and Strategy for State-Level Focus
[00:21:00]: Plans for Geographic Expansion of Longevity Policy Initiatives
[00:23:00]: Political Climate and Opportunities with the Current Administration
[00:25:00]: Shifts in Federal Attitudes Toward Longevity and Healthspan
[00:27:00]: Demographics, Policy Momentum, and National Health Priorities
[00:29:00]: Prevention Versus Treatment: Shifting Policy Mindsets
[00:32:00]: Communicating Policy Opportunities to a Wider Audience
[00:34:00]: Ensuring Longevity Policy Remains Bipartisan
[00:35:00]: Intersection of Policy, Science, and Public Engagement
[00:37:00]: Funding and Regulatory Challenges in Longevity Research
[00:39:00]: Barriers in Clinical Trials and Policy Modernization
[00:40:00]: Strategies for Communicating Longevity Science to Policymakers
[00:44:00]: Framing Longevity for Policy Impact and Public Understanding
[00:48:00]: Future Vision and Milestones for Longevity Policy
[00:51:00]: How Individuals and Organizations Can Support Longevity Advocacy
[00:55:00]: Practical Longevity Advice and Episode Conclusion

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

Aging is more than disease—it’s the steady decline of function. In this episode of Longevity by Design, Dr. Gil Blander speaks with physicist-turned-biotech innovator Dr. Peter Fedichev about why resilience, not diseases, holds the key to longer lives.

Peter explains how his background in theoretical physics shaped his approach to biology and aging. He outlines why startups, not large institutions, are now leading innovation in longevity science. Drawing from physics, he describes aging as a series of “jumps” between states, each leaving the body more fragile.

The discussion moves from the limits of current drugs to the promise of new approaches. Peter argues that reducing fluctuations and increasing molecular fidelity could unlock far greater gains in healthspan and lifespan. Listeners gain a fresh lens on what drives aging, where the real breakthroughs may come from, and why the next frontier in longevity will require rethinking the problem altogether.

Guest-at-a-Glance

💡 Name: Peter Fedichev

💡 What they do: Founder & CEO

💡 Company: Gero (biotech company using AI to study aging)

💡 Noteworthy: Physicist turned biotech leader applying statistical physics to model biological age and resilience

💡 Where to find them: LinkedIn

Episode highlights:

[00:00:00] Opening Thoughts on Venture Capital
[00:00:58] Host Introduction and Show Welcome
[00:01:25] Guest Background: From Physics to Biotech
[00:02:42] Physics as a Tool for Biology
[00:05:19] Why Switch From Physics to Biology
[00:06:20] Discovering Aging Through Naked Mole Rats
[00:09:27] Defining Professional Goal in Aging
[00:10:15] Challenges in Crossing Disciplines
[00:11:58] Startups Driving Scientific Innovation
[00:14:09] Pharma, Biotech, and Market Dynamics
[00:16:23] Aging as a System-Level Problem
[00:18:56] Drugs With Modest Longevity Effects
[00:20:14] Aging vs. Disease: Functional Decline
[00:23:48] Squaring the Curve vs. True Aging
[00:26:02] Sponsor Message: InsideTracker
[00:26:56] Resilience in 90-Year-Olds
[00:27:55] Measuring Health With Longitudinal Data
[00:30:07] Aging as Jumps Between States
[00:31:49] Declining Recovery Times With Age
[00:33:33] Cancer Risk and Immune Decline
[00:34:30] Rare Events Driving Aging Jumps
[00:36:15] Mutations, Epimutations, and Reliability Theory
[00:38:31] Perfect Storm Failures in Aging
[00:40:26] Cancer, Diabetes, and System Crashes
[00:42:09] Searching for a Master Switch
[00:43:41] Reducing Physiological Noise to Slow Aging
[00:45:54] Targeting Fluctuations as Drug Strategy
[00:47:13] Stress, Hormesis, and Adaptation
[00:49:27] Evolutionary Role of Stress Responses
[00:50:58] Model Organisms: Mice vs. Dogs
[00:53:41] Why Dogs Mirror Human Aging
[00:55:42] Regulatory Edge: Aging Trials in Dogs
[00:56:42] Next-Gen Drugs Beyond GLP-1
[00:58:22] Epigenetic Rejuvenation vs. Noise Control
[01:00:11] Key Targets: Chromatin Modifiers
[01:01:10] Measuring Fluctuations With Biomarkers
[01:02:58] Dogs as Proof-of-Concept Model
[01:03:23] Defining Jumps Through Omics Data

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

In this episode of Longevity by Design, Dr. Gil Blander welcomes Dr. Eric Verdin, President and CEO of the Buck Institute for Research on Aging. Eric discusses the science behind therapeutic plasma exchange (TPE) and its potential to slow biological aging in humans. The conversation explores findings from a recent clinical trial, including measurable age reversal using epigenetic clocks.

Eric explains how removing and replacing plasma can dilute pro-aging factors in the blood, a concept inspired by earlier animal studies on parabiosis. He also describes why rigorous, placebo-controlled human trials are crucial for validating longevity interventions and distinguishing the field from hype-driven wellness trends.

The episode also highlights how omics data, such as metabolomics and proteomics, are shaping a new era of precision aging research. Eric emphasizes the value of lifestyle interventions as a foundation and sees future opportunities in combining TPE with personalized strategies to extend healthspan.

Guest-at-a-Glance

💡 Name: Dr. Eric Verdin

💡 What they do: President and CEO

💡 Company: Buck Institute for Research on Aging

💡 Noteworthy: Physician-scientist pioneering human aging research through epigenetics, metabolism, and translational science.

💡 Where to find him: LinkedIn

Episode highlights:

[00:00] Introduction to Longevity and Healthspan
[01:07] Meet Dr. Eric Verde: A Pioneer in Aging Research
[02:24] Exploring Therapeutic Plasma Exchange
[03:08] The Science Behind Heterochronic Parabiosis
[07:17] Clinical Trials and Methodologies
[12:58] The Role of Omics in Precision Medicine
[17:20] Epigenetic Clocks and Aging
[22:04] Therapeutic Plasma Exchange: Results and Implications
[26:22] Exploring Frequency and Efficacy of Treatments
[28:23] Biomarkers and Predictive Models
[31:33] Safety Profile and Side Effects
[33:28] Intrinsic Capacity and Aging Metrics
[36:58] Combining Treatments with Lifestyle Changes
[44:26] Future Directions and Recommendations
[49:08] Conclusion and Final Thoughts

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

In this episode of Longevity by Design, Dr. Gil Blander sits down with Dr. Keith Diaz, Associate Professor of Behavioral Medicine at Columbia University Irving Medical Center, to unpack the hidden health risks of prolonged sitting.

Keith explains why even daily exercise isn't enough to counteract the effects of sedentary behavior. Drawing on his lab's findings, he shares a simple but powerful prescription: five minutes of light walking every hour. That small change can lower blood pressure, improve mood, and reduce fatigue, without needing to break a sweat.

The conversation also explores how modern work and home environments are built around sitting, and what it takes to build smarter habits. From treadmill desks to family walks, Keith offers practical strategies that make movement part of everyday life. Whether you're an employer, a clinician, or just desk-bound, this episode helps you rethink how you move through your day.

Guest-at-a-Glance

💡 Name: Dr. Keith Diaz

💡 What they do: Associate Professor

💡 Company: Columbia University Irving Medical Center

💡 Noteworthy: Leading researcher on sedentary behavior, cardiovascular health, and wearable tech in clinical care.

💡 Where to find them:LinkedIn

Episode highlights:

[00:00:00] Introduction: The Evolution of Television Viewing Habits
[00:00:23] Welcome to Longevity By Design
[00:00:33] Introducing Dr. Ki Diaz
[00:02:14] The Impact of Sedentary Behavior
[00:04:23] The Physiology of Sitting
[00:09:59] Exercise vs. Sedentary Lifestyle
[00:16:56] Movement Breaks: How Short is Beneficial?
[00:27:45] The Role of Wearable Devices
[00:31:51] Integrating Movement into Daily Routines
[00:33:34] Behavioral Changes and Personal Strategies
[00:34:55] The Benefits of Movement Breaks at Work
[00:37:26] Wearables and Their Impact on Health
[00:40:16] Clinicians' Role in Promoting Movement
[00:43:09] Tailoring Movement to Individual Lifestyles
[00:47:28] Incentives for Employers and Insurers
[00:52:46] Personal Movement Hacks and Daily Routines
[00:58:16] Future Research and Final Thoughts

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

In this episode, Dr. Gil Blander welcomes Dr. Haim Cohen to Longevity by Design to explore his revolutionary approach to understanding aging. Haim's team analyzed acetylation sites across 107 mammalian species, creating its most extensive comparative study. This computational approach revealed specific post-translational modifications that evolved exclusively in long-lived animals.

The research identifies critical pathways where evolution engineered longevity solutions. These acetylation changes affect DNA repair, cell cycle regulation, and mitochondrial function. Unlike traditional aging research focusing on single pathways like mTOR or caloric restriction, Haim's unbiased screening simultaneously reveals multiple longevity targets. Evolution provided a natural laboratory for testing anti-aging modifications over millions of years.

The findings offer exciting therapeutic possibilities for human longevity. Haim's team is now creating transgenic mice to test whether mimicking these evolutionary changes can extend lifespan in the lab. This research suggests humans could potentially "accelerate evolution" by implementing modifications that nature has already proven effective in whales, elephants, and other long-lived species.

Guest-at-a-Glance

💡 Name: Dr. Haim Cohen

 💡 What they do: Professor of Molecular Genetics focused on the biology of aging

 💡 Institution(s): Bar-Ilan University (Israel); Founder & Director, Minerva Israel-Germany Center forBiological Mechanisms of Aging; Founder & Director, Sagol Center for Human Health and Longevity

 💡 Noteworthy: Global leader in aging research; author of 75+ peer-reviewed papers, including work showing SIRT6 over-expression can extend mouse lifespan by ~30 percent

 💡 Where to find them: Bar-Ilan University faculty page

Episode highlights:

[00:00:00] Introduction
[00:01:00] Dr. Haim Cohen background and SIRT6 research update
[00:05:50] Gender-specific effects in aging research
[00:07:40] Introduction to the groundbreaking Nature paper on acetylation
[00:08:30] What is acetylation and why study it
[00:11:40] Study design across 107 mammalian species
[00:15:00] Using evolution as a research laboratory
[00:19:00] Key findings and statistical approach
[00:28:00] Validating specific proteins - CBS and hydrogen sulfide
[00:31:30] Mitochondrial acetylation and metabolism
[00:34:10] DNA repair pathways and the Peto Paradox
[00:35:00] Cancer prevention mechanisms in large animals
[00:38:30] P53 tumor suppressor conservation
[00:40:50] Cat family longevity anomaly
[00:42:10] Therapeutic implications and drug development
[00:45:00] Targeting proteins versus modifications
[00:47:40] Study limitations and future validation
[00:49:20] Comparing effects to existing longevity interventions
[00:51:00] Implications for human longevity
[00:55:00] Dr. Cohen's top tip for longevity

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

On this episode of Longevity by Design, Dr. Gil Blander sits down with Dr. Karl Pfleger, aging biotechnology investor and creator of AgingBiotech.info, to dissect the rapidly evolving field of aging therapeutics. Karl breaks down the sector into two main categories: interventions that slow aging rates versus rejuvenation strategies that repair accumulated damage.

Karl highlights the most promising areas in his investment portfolio, including senolytics for clearing senescent cells and epigenetic reprogramming technologies. He explains why current aging clocks aren't ready for clinical use and discusses the limitations of popular interventions like GLP-1 drugs and fasting protocols. The conversation reveals that 14 Phase 3 clinical trials are currently testing core aging therapeutics.

The discussion covers recent FDA approvals for ATTR treatments and stem cell therapies, signaling the field's maturation. Karl emphasizes that meaningful life extension requires a "divide and conquer" strategy, targeting multiple aging mechanisms simultaneously rather than relying on single interventions. Despite exciting therapeutic developments, he maintains that optimizing diet, exercise, and sleep remains the most impactful strategy for extending healthspan today.

Guest-at-a-Glance

💡 Name: Dr. Karl Pfleger

💡 What they do: Angel investor, philanthropist, and advocate in aging and longevity biotechnology

💡 Institution(s): Creator and maintainer of AgingBiotech.info (comprehensive public database of 400+ aging companies)

💡 Noteworthy: Exclusively invests in aging/longevity sector with 15+ portfolio companies targeting damage repair approaches

💡 Where to find them: LinkedIn | AgingBiotech.info | X (Twitter)

Episode highlights:

00:00:00 Introduction to GLP-1 Drugs and Their Impact
00:00:56 Meet Dr. Karl Pfleger: A Pioneer in Aging and Longevity
00:02:50 Karl Pfleger's Journey from Tech to Aging Biology
00:05:18 The Current State of Longevity Biotech
00:09:47 Exciting Developments in Rejuvenation Biotechnology
00:24:17 Aging Biotech Info: A Comprehensive Resource
00:31:59 Future Plans for Aging Biotech Info
00:36:51 The Obesity Revolution: GLP-1 Receptor Agonists
00:40:29 Global Obesity Rates and GLP-1 Drugs
00:40:43 Potential Benefits and Limitations of GLP-1 Drugs
00:42:13 Muscle Atrophy and Side Effects of GLP-1 Drugs
00:44:12 Emerging Muscle Aging Treatments
00:46:10 Biotech Companies and Obesity Programs
00:46:53 Public vs. Private Biotech Companies
00:49:12 Fasting and Calorie Restriction
00:55:20 Blood Transfusions and Parabiosis
00:58:09 Metformin and N-of-1 Experiments
00:59:13 Comprehensive Aging Interventions
01:03:54 Diagnostics and Aging Clocks
01:13:49 Future of Aging Interventions
01:16:07 Top Tips for Health and Longevity

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

Gil and Eric discuss Eric’s book, Super Agers, and the inspiration behind it: a 98-year-old patient who exemplified healthy aging. They explore the five dimensions of healthspan optimization: lifestyle, omics, the immune system, and the role of data and AI in personalized medicine. Eric highlights how AI can analyze multi-layered data to provide personalized recommendations for preventing age-related diseases.

The conversation also explores the importance of exercise, sleep, and social connection for healthy aging, as well as the risks associated with high-dose statins. Eric emphasizes the need for a shift towards preventative care, using data and AI to identify and address individual risks. He stresses the power of lifestyle changes, rather than supplements, in improving long-term health outcomes.

Guest-at-a-Glance

💡 Name: Dr. Eric Topol 

💡What they do: Founder and Director 

💡Company: Scripps Research Translational Institute

💡Noteworthy: Genomics pioneer, digital medicine innovator, and preventative care advocate

Episode highlights:

[00:00] The Impact of Social Isolation on Health
[01:19] Meet Dr. Eric Topol: A Pioneer in Medicine
[03:16] Dr. Topol's Personal Journey into Medicine
[05:31] The Early Days of Genetic Therapy
[07:54] Insights from Dr. Topol's Book: Super Agile
[13:02] The Role of Genetics in Longevity
[14:22] The Five Dimensions of Healthspan
[20:08] The Power of Exercise and Diet
[23:58] The Truth About Supplements
[32:38] The Importance of Sleep
[36:07] The Value of Social Relationships
[38:02] The Benefits of Nature and Social Interaction
[39:17] Exploring Longevity Drugs: Metformin and Rapamycin
[40:10] Risks and Benefits of Longevity Treatments
[41:56] The Potential of GLP-1 Drugs
[46:41] Statins and Their Impact on Health
[51:11] Emerging Cancer Detection Technologies
[56:15] The Role of AI and Polygenic Scores in Healthcare
[57:36] Preventing Alzheimer's Disease
[01:01:14] The Future of Longevity and Healthspan

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

In this episode of Longevity By Design, Dr. Layne Norton, Founder of BioLayne and Carbon app, joins Gil Blander to discuss optimizing nutrition and fitness for a longer, healthier life. Layne emphasizes the importance of prioritizing scientific evidence over popular narratives, highlighting how easily isolated studies can be misinterpreted. He stresses the power of personalized approaches to nutrition and fitness, advocating for a critical approach to information consumption.

Layne dives into the complexities of protein intake, challenging common misconceptions. He advocates for a protein intake above the recommended daily allowance, stressing the role of muscle mass in overall health and longevity. Layne explains the importance of resistance training, even for older adults, to maintain muscle mass and reduce fall risk. He advocates for finding enjoyment in exercise, stressing that passion fuels consistency.

Beyond physical health, Layne underscores the impact of mental health on longevity. He discusses the detrimental effects of stress, provides practical stress management tips, and encourages healthy boundaries. Layne’s holistic approach highlights lifestyle factors, nutrition, training, and stress management , as key drivers of a longer, healthier lifespan.

Guest-at-a-Glance

💡 Name: Dr. Layne Norton 

💡What they do:  Owner of BioLayne

💡Company: BioLayne and the Carbon app

💡Noteworthy: Nutrition scientist, fitness expert, and evidence-based educator bridging the gap between science and application.

Episode highlights:

[00:00:52] Introduction to Longevity By Design
[00:01:03] Meet Dr. Layne Norton
[00:02:00] Layne's Academic Journey
[00:03:48] Choosing the Right Advisor
[00:06:56] The Importance of Critical Analysis in Research
[00:10:00] Transitioning from Academia to Public Communication
[00:11:29] The Role of Social Media in Science Communication
[00:13:33] Launching a Podcast and Future Plans
[00:17:09] Understanding Risk and Misconceptions in Health
[00:22:59] The Importance of Protein in Aging
[00:41:50] Protein Consumption for Non-Daily Lifters
[00:43:07] Debunking the Protein Timing Myth
[00:45:31] Protein Distribution and Muscle Growth
[00:50:09] Resistance Training for Older Adults
[00:53:45] The Importance of Recovery and Sleep
[00:56:15] Managing Psychological Stress
[01:01:31] Wearable Data and Subjective Feelings
[01:04:42] The Impact of GLP-1 Agonists on Weight Loss
[01:09:47] Supplements for Health and Longevity
[01:13:32] AI in Health and Wellness
[01:14:46] Advice for Different Life Stages
[01:17:45] Top Tips for Health and Longevity

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

On this episode of Longevity by Design, Dr. Gil Blander sits down with Dr. Evelyne Bischof, President of the Healthy Longevity Medicine Society.  Evelyne discusses her background in internal medicine and oncology and how her work puzzling together patient diagnoses led her to the field of longevity medicine. She highlights the importance of optimizing health span, not just lifespan, and how healthy longevity medicine benefits not only individuals, but population health and the world economy as well.

Gil and Evelyne explore the difference between longevity medicine and traditional healthcare. Evelyne explains that longevity medicine uses a broader range of diagnostics, including advanced biomarkers, imaging, and cognitive tests. This approach aims to build a personalized health trajectory for each patient. They also discuss the role of AI in healthcare, with Evelyne expressing hope for faster, AI-driven diagnostics and drug discovery in the future.

Finally, they touch upon the Healthy Longevity Medicine Society, its mission to establish longevity medicine as a recognized medical discipline, and the exciting developments in the field, such as the SHARP study at the Sheba Longevity Center. Evelyne emphasizes the importance of being data-driven and encourages listeners to collect and track their own health data. She believes this empowers individuals to make informed decisions about their health and longevity.

Guest-at-a-Glance

💡 Name: Dr. Evelyne Bischof 

💡What they do: President

💡Company: Healthy Longevity Medicine Society (HLMS)

💡Noteworthy: Physician-scientist specializing in longevity and precision medicine.

💡 Where to find her:LinkedIn

Episode highlights:

[00:01:24] Meet Dr. Evelyne Bischof
[00:05:12] The Concept of Longevity Medicine
[00:08:42] Health Span vs. Lifespan
[00:11:39] The Role of Diagnostics in Longevity Medicine
[00:22:54] Global Landscape of Longevity Medicine
[00:29:50] Collaborations and Growth Initiatives
[00:30:30] Monthly Case Studies and Activities
[00:31:27] Membership and Target Audience
[00:34:42] Organizational Structure and Leadership
[00:39:52] Shiba Longevity Center Overview
[00:45:22] Future of Longevity Medicine
[00:50:27] Top Healthspan Tips and Final Thoughts

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

In this episode of Longevity by Design, our host, Dr. Gil Blander talks with Dr. Renee Deehan and Paul Fabian about Inside Tracker's new Healthspan Habits Score feature. This innovative tool analyzes data from wearable devices and daily journal entries to identify the most impactful habit to improve each week for better health span and longevity.

The guests explain how the algorithm processes up to 15 different variables, including sleep quality, step count, and lifestyle factors to create a personalized weekly score. Rather than overwhelming users with multiple recommendations, the report focuses on one key habit to change, applying behavioral science principles for sustainable improvement.

Deehan and Fabian detail how the system evaluates six weeks of data to identify trends and provide targeted recommendations, helping users bridge the gap between blood tests with actionable weekly guidance based on scientific research linking these habits to longevity outcomes.

Guest-at-a-Glance 

💡 Name: Dr. Renee Deehan 

💡 What she does: Senior Vice President of Science and Artificial Intelligence 

💡 Company: InsideTracker 

💡 Noteworthy: Expert in precision health with a PhD from UC Berkeley 

💡 Where to find her:LinkedIn

Guest-at-a-Glance 

💡 Name: Paul Fabian 

💡 What he does: Researcher 

💡 Company: InsideTracker 

💡 Noteworthy: Specializes in genetics,  exercise biomarkers, and data-driven health recommendations 

💡 Where to find him:LinkedIn

Episode highlights:

Introduction to Healthspan and Lifespan 00:00:00
Meet the Experts: Dr. Renee Dhan and Paul Fabian 00:01:07
Paul Fabian's Journey to Science 00:03:24
Introducing the Health Span Habits Core Tool 00:04:31
Inspiration Behind the Health Span Habits Core 00:05:07
How the Health Span Habits Core Works 00:06:40
Personalized Health Recommendations 00:08:02
How does  Insight Tracker turn intent into action 00:10:16
How the Health Span Habit Score is Calculated 00:13:25
The Importance of Bedtime Consistency 00:22:00
Behavioral Science in Health Tracking 00:25:35
User Feedback and Future Directions 00:31:38
Final Thoughts and Tips for Longevity 00:42:20 

We Appreciate You!
As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcast


For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast